Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-15

FDA Approved: TERIFLUNOMIDE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for Accord Healthcare Inc.'s Teriflunomide, finalizing regulatory action on the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)